European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai

[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

[ad_1] A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London,…

Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills

[ad_1] Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting…

Pfizer moves forward with once-daily version of weight loss pill after setbacks

[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says

[ad_1] Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee…

Investors want proof AI will aid drug discovery. Evidence may come in the second half

[ad_1] As investors peer into the future to envision which industries are ripe to be reshaped…

Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

[ad_1] Think a friend or colleague should be getting this newsletter? Share this link with them…

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

[ad_1] A sign with the company logo sits outside of the headquarters campus of Eli Lilly…

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…

Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic

[ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on…

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

[ad_1] Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for…

Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

[ad_1] Think a friend or colleague should be getting this newsletter? Share this link with them…

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…

Alphabet taps Eli Lilly’s Anat Ashkenazi as new CFO

[ad_1] A view of Google Headquarters in Mountain View, California, United States on April 16, 2024. …